...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer

,,, I wish one or the other would sell giving us lifers a chance to shed the years of frustrated investing with DM and gang...we as owners of ZCC still have no control of our shares,,unfathomable...its well past its time imo,,,,,as I see an unknown number of more years of uncertainty coming our way,,,

Share
New Message
Please login to post a reply